prednisolone has been researched along with Experimental Spinal Cord Ischemia in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " During a second infiltration of prednisolone acetate, the patient reported feeling a heat sensation in his legs and concomitantly developed facial flushing." | 4.86 | A rare case of paraplegia complicating a lumbar epidural infiltration. ( Berets, O; Defuentes, G; Dubecq, C; Escobar, E; Lapeyre, E; Rogez, D; Soula, M; Thefenne, L; Zing, E, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thefenne, L | 1 |
| Dubecq, C | 1 |
| Zing, E | 1 |
| Rogez, D | 1 |
| Soula, M | 1 |
| Escobar, E | 1 |
| Defuentes, G | 1 |
| Lapeyre, E | 1 |
| Berets, O | 1 |
| Jones, RL | 1 |
| Landers, MH | 1 |
| Zaidan, M | 1 |
| Lidove, O | 1 |
| Sacré, K | 1 |
| Klein, I | 1 |
| Papo, T | 1 |
1 review available for prednisolone and Experimental Spinal Cord Ischemia
| Article | Year |
|---|---|
A rare case of paraplegia complicating a lumbar epidural infiltration.
Topics: Anti-Inflammatory Agents; Arteries; Embolism; Flushing; Humans; Informed Consent; Injections, Epidur | 2010 |
2 other studies available for prednisolone and Experimental Spinal Cord Ischemia
| Article | Year |
|---|---|
Has rare case of paraplegia complicating a lumbar epidural infiltration been reported?
Topics: Anti-Inflammatory Agents; Humans; Injections, Epidural; Male; Paraplegia; Prednisolone; Radiculopath | 2011 |
"Fulminant" Behçet disease.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Atrophy; Azathio | 2011 |